Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3927 studies found for:    Open Studies | "Endocrine System Diseases"
Show Display Options
Rank Status Study
21 Recruiting Preservation of Ovarian Tissue and Chemo-Radiotherapy
Conditions: Endocrine Disorders of Female Reproductive System;   Secondary Infertility;   Infertility Involuntary
Intervention: Procedure: surgery
22 Recruiting Characteristics of Women With Reproductive Concerns
Condition: Endocrine Disorders of Female Reproductive System
Intervention:
23 Recruiting Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
Conditions: Schizophrenia;   Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorder With Hyperactivity
Intervention:
24 Unknown  Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
Conditions: Type 2 Diabetes Mellitus;   Insulin Resistance
Intervention: Drug: Resveratrol
25 Not yet recruiting Value of MRI in the Characterization of Ovarian Masses Unable to Classify With Ultrasound Using the International Ovarian Tumor Analysis (IOTA) Simple Rules
Condition: Patients With a Sonographically Unclassifiable Adnexal Mass Using the IOTA Simple Rules
Intervention: Other: Diffusion/Perfusion-weighted Magnetic Resonance Imaging
26 Recruiting Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Carbohydrate-Restricted Diet;   Dietary Supplement: Standard Antidiabetic Diet
27 Recruiting Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism
Conditions: Obesity;   Hypoandrogenism
Interventions: Drug: Clomiphene Citrate;   Drug: Placebo
28 Recruiting The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study
Conditions: Chronic Kidney Disease;   Type 2 Diabetes
Interventions: Drug: RTA 402;   Drug: Placebo
29 Recruiting Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
Conditions: Type 1 Diabetes Mellitus;   Nocturnal Hypoglycemia;   Recurrent Severe Hypoglycaemia
Interventions: Drug: Insulin aspart/glargine;   Drug: Insulin aspart/degludec
30 Unknown  Accuracy of Two CGM Systems Tested Simultaneously in Ambulatory Patients With Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1;   Blood Glucose
Interventions: Device: Guardian Enlite sensor;   Device: Dexcom G4 platinum sensor
31 Recruiting Resveratrol and First-degree Relatives of Type 2 Diabetic Patients
Condition: Pre-diabetes
Interventions: Dietary Supplement: placebo;   Dietary Supplement: resveratrol
32 Unknown  A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus
Interventions: Drug: HM11260C;   Drug: Placebo;   Drug: Victoza
33 Unknown  Effects of Alogliptin on Pancreatic Beta Cell Function
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin;   Drug: Metformin 750 mg
34 Recruiting Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: PEG-somatropin
35 Recruiting Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
Condition: Adult Growth Hormone Deficiency (AGHD)
Intervention: Drug: somavaratan
36 Recruiting Gut Microbiome Mediated Effects of Inulin Supplementation on Mineral and Bone Metabolism in Hemodialysis Patients
Conditions: Bone Diseases, Endocrine;   Nutritional and Metabolic Diseases
Interventions: Dietary Supplement: Inulin;   Dietary Supplement: Maltodextrin
37 Recruiting Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children
Interventions: Drug: NNC0195-0092;   Drug: Norditropin® FlexPro® pen
38 Recruiting Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency
Condition: Growth Hormone Deficiency With Pituitary Anomalies
Interventions: Drug: Macimorelin;   Drug: Insulin
39 Recruiting Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (VRS-317)
Conditions: Pediatric Growth Hormone Deficiency;   Growth Disorders
Intervention: Drug: VRS-317
40 Recruiting Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)
Condition: Growth Hormone Deficiency
Intervention: Biological: PEG-somatropin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years